Piper Sandler analysts now expect the challenges weighing on veterinary medicine to continue through 2027, extending a recovery timeline that many practice owners had hoped would shorten.

The investment bank's outlook, reported by Investing.com, signals that the pressures building across the sector since the post-pandemic demand surge are structural rather than cyclical — and that practices, distributors, and animal health companies should plan for several more years of constrained conditions rather than a near-term rebound.

Why the 2027 horizon matters

For independent practices and corporate groups alike, a multi-year downcycle changes planning assumptions. Hiring, expansion, equipment purchases, and valuation expectations all shift when a sell-side analyst house frames the slowdown as lasting into 2027 rather than resolving within a year or two.

Piper Sandler covers the major players in animal health and veterinary services, and its sector calls carry weight with the investors who fund practice acquisitions and pharmaceutical pipelines. A forecast that pushes recovery to 2027 suggests the firm sees persistent softness in the fundamentals that drive the sector — rather than a temporary correction after the visit-volume spikes of 2020–2022.

What changes at the practice level

If the headwinds hold through 2027, practice owners face a longer stretch of managing costs carefully:

• Tighter client spending on discretionary services and preventive care
• Continued pressure on visit volumes after the pandemic-era surge normalized
• Higher operating costs, including staffing, sustaining margins
• More cautious expansion and acquisition activity across the corporate sector

The report does not signal distress so much as duration: the sector's challenges — normalized demand, cost inflation, and softer consumer spending — are expected to take years to work through, not quarters.

The broader context

Veterinary medicine boomed during the pandemic, with record appointment volumes, aggressive clinic expansion, and surging valuations for practice groups. The correction that followed has hit segments of the industry unevenly, and analyst houses including Piper Sandler have tracked the slowdown through their coverage of animal health manufacturers, distributors, and practice consolidators.

Extending the challenging environment to 2027 implies the industry will absorb the post-pandemic reset over roughly a five-year span — a timeline that puts recovery planning, not crisis management, at the center of practice strategy through the middle of the decade.

How quickly client visit volumes and discretionary spending recover will determine whether the 2027 timeline holds or shortens as economic conditions evolve.